Business Context and Reporting Period
Company: U.S. Physical Therapy, Inc. (USPH)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2024
Business Overview: USPH operates two reportable segments: Physical Therapy Operations (outpatient clinics providing orthopedic, neurological, and sports injury care) and Industrial Injury Prevention (IIP) Services (onsite injury prevention and rehabilitation for employers). As of December 31, 2024, the company owned or managed 729 clinics across 43 states, plus 39 managed clinics under contract.
Key Financial Metrics
| Metric | 2024 (in thousands) | 2023 (in thousands) |
|---|---|---|
| Net Revenue | $671,345 | $604,802 |
| Operating Income | $63,213 | $52,061 |
| Net Income (Total) | $45,600 | $37,220 |
| Net Income Attributable to USPH Shareholders | $31,424 | $28,239 |
| Diluted EPS (USPH Shareholders) | $1.84 | $1.28 |
| Adjusted EBITDA (Non-GAAP) | $81,768 | $77,912 |
| Cash and Cash Equivalents (Year End) | $41,362 | $152,825 |
| Total Debt Outstanding | $154,578 | $148,150 |
| Available Credit | $164,000 | $175,000 |
Material Changes vs. Prior Period
- Revenue Growth: Net revenue increased 11.0% to $671.3 million, driven by 58 net new clinic additions and a 1.9% increase in net rate per patient visit ($104.71 vs. $102.80).
- Profitability: Operating income rose 21.4% to $63.2 million. This improvement was aided by the absence of the $17.5 million goodwill impairment charge recorded in 2023.
- Acquisitions: Significant M&A activity included the October 2024 acquisition of a 50% interest in MSO Metro, LLC (50 clinics) for approximately $76.5 million, and the November 2024 acquisition of an 8-clinic practice.
- Clinic Closures: The company closed 45 underperforming clinics in 2024, incurring $4.4 million in closure costs, compared to 15 closures in 2023.
- Cash Position: Cash and cash equivalents decreased significantly from $152.8 million to $41.4 million, primarily due to $149.5 million used in investing activities for acquisitions and fixed assets.
Guidance, Outlook, and Risks
- Dividend Increase: On February 25, 2025, the Board raised the quarterly dividend from $0.44 to $0.45 per share.
- Medicare Reimbursement: The company expects a 2.9% decrease in Medicare reimbursement rates for 2025 compared to 2024 rates.
- Subsequent Events: In February 2025, the company completed the sale of a business unit for $0.7 million (after a $2.4 million impairment) and acquired a 65% interest in a 3-clinic practice.
- Key Risks:
- Regulatory: Dependence on Medicare/Medicaid reimbursement rates and potential retroactive reductions due to audits.
- Operational: Challenges in recruiting and retaining qualified physical therapists in a competitive labor market.
- Financial: Obligations related to "put rights" in acquisition agreements, which could require the company to purchase non-controlling interests at predetermined multiples of earnings.
- Cybersecurity: Risks associated with data breaches of patient health information (HIPAA/HITECH).
Investor Verification Checklist
- Acquisition Integration: Verify the financial performance and integration progress of the MSO Metro, LLC acquisition (50 clinics) and other 2024 add-ons.
- Medicare Impact: Assess the sensitivity of the 2025 financial model to the projected 2.9% Medicare rate cut.
- Non-Controlling Interest (NCI) Obligations: Review the $269.0 million carrying value of redeemable non-controlling interest and the potential cash outflow if partners exercise put rights.
- Cash Flow Sustainability: Monitor operating cash flow generation given the significant reduction in cash reserves from $152.8M to $41.4M.
- Clinic Closure Costs: Evaluate if the $4.4 million in closure costs represents a one-time event or a trend of underperforming assets.